Sonoblate

Sonablate Corp. is a privately held medical device manufacturer headquartered in Charlotte, North Carolina. Founded in 2004, the company specializes in focused-ultrasound technology designed to deliver targeted tissue ablation while minimizing damage to surrounding healthy tissue. Its flagship Sonablate HIFU system is used by physicians for prostate-focused treatment applications, including focal therapy.

Sonablate develops focused-ultrasound medical devices that help physicians deliver targeted, minimally invasive treatment for prostate disease.
The company supports physicians and healthcare institutions through medical equipment, clinical education, technical support, and international distribution. Its operations span the United States and international markets, with manufacturing and product development in Indianapolis and customer support in the United Kingdom. Sonablate reports that its technology has been used to treat more than 70,000 patients worldwide and is available in over 50 countries. In the United States, Sonablate HIFU received FDA clearance for the ablation of prostate tissue in 2015.